Quality Control Manager

Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine.

Patients with hematologic malignancies have been successfully treated with cell therapies.

However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers.

And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer…